A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Conditions
Follicular Lymphoma · Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Georgetown University (Data Collection Only), Washington D.C., District of Columbia, United States
Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge, New Jersey, United States
Hackensack Meridian Health (Data collection only), Hackensack, New Jersey, United States
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Suffolk- Commack (Limited protocol activities), Commack, New York, United States
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre, New York, United States
Study leads
Lorenzo Falchi, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center